1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. CORMEDIX INC
CorMedix Inc XNAS: CRMD

CorMedix Inc Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (...

Read More
11.65 -0.51 (-4.19%)
33.16% Fall from 52W High
3.3M
XNAS Volume

XNAS 21 Oct, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Positive Outlook
CorMedix rises on Monday as it raises annual sales outlook by over 10% to about $375 million See details
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Mid Valuation
42.0 / 100
Momentum Score
Technically Neutral
56.6 / 100
Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM
Analyst Price Target
19
1Yr Price target upside is 67%
7 analysts

11

S

8

W

6

O

0

T

SWOT Analysis

CorMedix Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..